Editas Medicine is a clinical‑stage biotechnology company that harnesses CRISPR/Cas9 and Cas12a genome‑editing platforms to develop durable, precision therapies for genetic and blood disorders, including sickle cell disease, beta‑thalassemia, and ocular conditions. The company’s pipeline spans in‑vivo editing, engineered cell medicines, and hematopoietic stem‑cell therapies, aiming to translate cutting‑edge genomics into first‑in‑class treatments. Editas differentiates itself through a cohesive, collaborative culture—referred to as "One Editas"—and a dedicated team of scientists who prioritize patient impact and scientific rigor. With a robust manufacturing and commercialization strategy, the firm is positioned to bring transformative genomic medicines to patients worldwide.
Open Positions
Director, Toxicology
PhD in toxicology. 10+ years of industry experience, specializing in toxicology & genomics. Experience with GLP/non-GLP studies & regulatory submissions
Senior Director, Genomics & Bioinformatics
PhD in Bio/Bioinformatics, 12+ yrs biotech/pharma exp. Deep expertise in CRISPR/Cas12a. Proven track record on off-target analysis & regulatory submissions
Associate Scientist, Genomics and Bioinformatics
Minimum 5+ years of relevant experience in industry, Bachelor's degree in cell biology or related field
Director, Project Management
8-10 years of biotech/pharma experience, with 3-5 years in program management; bachelor's degree in life sciences or related subjects; experience managing multiple programs, cross-functional teams, and project management tools
Senior Scientist, Cell and Molecular Biology, Gene Editing
Ph.D. in cell and molecular biology or a related field with 6+ years of industry experience and extensive molecular biology expertise